Evidence map›Paper›PMID 36503573›Full record

ArticleJournal of the International Neuropsychological Society : JINS2023

Development and application of novel performance validity metrics for computerized neurocognitive batteries.

J Cobb Scott, Tyler M Moore, David R Roalf, Theodore D Satterthwaite, Daniel H Wolf, Allison M Port, Ellyn R Butler, Kosha Ruparel, Caroline M Nievergelt, Victoria B Risbrough and 3 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the International Neuropsychological Society : JINS, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Test-Retest Reliability of a Computerized Neurocognitive Battery in School-Age Children with HIV in Botswana.Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

J Cobb ScottDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.ORCID 0000-0001-6538-9043
Tyler M MooreDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
David R RoalfDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Theodore D SatterthwaiteDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Daniel H WolfDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Allison M PortDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ellyn R ButlerDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Kosha RuparelDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Caroline M NievergeltCenter for Excellent in Stress and Mental Health, VA San Diego Healthcare System, San Diego, CA, USA.
Victoria B RisbroughCenter for Excellent in Stress and Mental Health, VA San Diego Healthcare System, San Diego, CA, USA.
Dewleen G BakerCenter for Excellent in Stress and Mental Health, VA San Diego Healthcare System, San Diego, CA, USA.
Raquel E GurDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Ruben C GurDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
University of Pennsylvania · USUniversity of California San Diego · USChildren's Hospital of Philadelphia · USPhiladelphia VA Medical Center · US

Funding

Neurodevelopmental Genomics: Trajectories of Complex PhenotypesRC2MH089983 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 2009 to 2011
$14.3M
SCHIZOPHRENIA: A NEUROPSYCHIATRIC PERSPECTIVET32MH019112 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E · 1990 to 2024
$6.2M
Evolution of Psychosis in Youth: Multimodal Risk and Resilience MarkersR01MH119219 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RAQUEL E, GUR, RUBEN C. · 2019 to 2023
$3.8M
Creating an adaptive screening tool for detecting neurocognitive deficits and psychopathology across the lifespanR01MH117014 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI GUR, RUBEN C. · 2019 to 2022
$2.9M
Impact of TBI and Cognitive Decline on Alzheimer's Disease Brain-Derived Exosome CargoRF1AG079303 · NIA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI RISBROUGH, VICTORIA B, RISSMAN, ROBERT · 2023 to 2023
$1.9M
A Computerized Neurocognitive Battery for Use in Youth Affected by HIV in Resource-limited SettingsR01HD095278 · NICHD · CHILDREN'S HOSP OF PHILADELPHIA · PI LOWENTHAL, ELIZABETH DAWN, SCOTT, JAMES COBB · 2018 to 2021
$1.6M
BLRD VA IK6 BX006186NIA NIH HHS RF1 AG079303NICHD NIH HHS R01 HD095278NIMH NIH HHS R01 MH117014NIMH NIH HHS R01 MH119219NIMH NIH HHS RC2 MH089983NIMH NIH HHS T32 MH019112
6 · The paper itself

Abstract

objectivesData from neurocognitive assessments may not be accurate in the context of factors impacting validity, such as disengagement, unmotivated responding, or intentional underperformance. Performance validity tests (PVTs) were developed to address these phenomena and assess underperformance on neurocognitive tests. However, PVTs can be burdensome, rely on cutoff scores that reduce information, do not examine potential variations in task engagement across a battery, and are typically not well-suited to acquisition of large cognitive datasets. Here we describe the development of novel performance validity measures that could address some of these limitations by leveraging psychometric concepts using data embedded within the Penn Computerized Neurocognitive Battery (PennCNB).

methodsWe first developed these validity measures using simulations of invalid response patterns with parameters drawn from real data. Next, we examined their application in two large, independent samples: 1) children and adolescents from the Philadelphia Neurodevelopmental Cohort (

resultsOur performance validity metrics detected patterns of invalid responding in simulated data, even at subtle levels. Furthermore, a combination of these metrics significantly predicted previously established validity rules for these tests in both developmental and adult datasets. Moreover, most clinical diagnostic groups did not show reduced validity estimates.

conclusionsThese results provide proof-of-concept evidence for multivariate, data-driven performance validity metrics. These metrics offer a novel method for determining the performance validity for individual neurocognitive tests that is scalable, applicable across different tests, less burdensome, and dimensional. However, more research is needed into their application.

Indexed as

BenchmarkingMalingeringAdolescentAdultChildHumansMental Status and Dementia TestsNeuropsychological TestsPsychometricsReproducibility of Resultsitem response theorylearning and memory testsmalingeringneuropsychological testingpsychometricsvalidity

Identifiers

PMID36503573
PMCPMC10258222
OpenAlexW4311201307

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.